OCD is associated with a cascade of psychopathology, comorbidity, and functional impairment extending into adulthood if left untreated or undertreated. Fortunately, cognitive-behavioral therapy (CBT) involving exposure plus response prevention (ERP), pharmacotherapy with serotonin reuptake inhibitors (SRIs), and their combination have each been found both efficacious and cost-effective. Now that efficacy has been well established in tightly controlled settings, the next research frontier to be crossed in OCD involves examination of adaptations to treatment – whether adapting evidence-based protocols to primarily clinical settings, where more severe and complex clinical presentations often receive care, to different delivery modalities (e.g., telehealth), or to clinical presentations found less responsive to the established empirically supported interventions.

Designed for intermediate-level professionals who work in clinical settings, this webinar will offer updates from two OCD researchers on some of the most pressing issues at hand. Dr. Franklin will focus his presentation time on work pertaining to the pediatric OCD program, discussing responses to combined treatment via telehealth, dose-response effects with patients receiving an SRI, and predictors and moderators of response. Dr. Schwartz will concentrate in her presentation time on outcomes from a national survey of practitioners experienced with OCD regarding their clinical management of cases in which “not just right” or disgust-related phenomenology were present. The practical application of these findings will be highlighted, and there will be a moderated Q&A session to address audience questions at the end of the presentation. Less...

Learning Objectives

• Identify at least one benefit and one limitation of using telehealth for ERP in higher levels of pediatric OCD care.

• Summarize the difference between "non-fear-based" and fear-based OCD and the rationale for the need to modify standard ERP for non-fear-based presentations.

• Describe at least three evidence-informed modifications to ERP that could enhance treatment for disgust and “Not Just Right” symptoms in OCD.

Learning Levels

• Intermediate

Agenda

1 pm ET Welcome and speaker introduction

1:05 pm Pediatric OCD: Recent Empirical Findings

• Comparison of in-person provision of ERP to telehealth for patients treated at higher levels of care

• Exploration of SRI dose-response effects

• Moderators and predictors of outcome

1:25 pm Modifying Exposure Plus Response Prevention for Non-Fear-Based Forms of OCD

• “Not Just Right” and disgust symptoms are prevalent in OCD and respond poorly to ERP

• Evidence that ERP might be tailored to enhance fit with non-fear-based pathology

• Results from a national survey of practitioners experienced with OCD reporting on their experience using ERP with “Not Just Right” and disgust symptoms

1:50 pm Implications of These Research Findings for Clinical Practice

• Application of telehealth approaches for pediatric OCD

• Concomitant SRIs and ERP: How best to navigate?

• Treatment development with “Not Just Right” and disgust-based presentations

2:15 pm Moderated Q&A

2:28 pm Closure